Statement on White House Tariff Announcements

*:last-child]:mb-0 [&>*:last-child]:pb-0 [&>p]:font-normal text-left [&>.prm-button-bar]:justify-start [&_.portable-text-link]:font-semibold [&_.portable-text-link]:underline [&_.prm-button-bar_a]:no-underline [&_li]:text-light-gray [&_p]:text-light-gray">

By Soumi Saha, Senior Vice President of Government Affairs, Premier Inc.

Targeted and thoughtful tariffs on healthcare products could offer a chance to bolster supply resilience and ensure access to critical medical supplies. But they cannot live in a vacuum, lest they become just another cost without real impact. Premier believes that tariffs need to be put to work, funding innovation that ensures long-term stability and a stronger, more resilient U.S. supply chain.

Premier champions a comprehensive strategy, including leveraging tariff funds to expand domestic and nearshore manufacturing of essential medical products, incentivizing healthcare providers and the U.S. government to buy American, and prioritizing U.S. Food and Drug Administration (FDA) approvals for domestically produced medical goods.

A strong, sustainable supply chain isn't just good policy-it's the foundation of high-quality, affordable and accessible healthcare for all Americans. Premier stands ready to partner with policymakers to build lasting solutions that make a difference and ensure American patients have access to the medical products they need.